Temisis Therapeutics announced that it has received 1.6 million in a round of funding on December 18, 2020. The transaction included participation from returning investor Plant Advanced Technologies SA (ENXTPA:ALPAT) and new investor Financiere Hoche Bains-Les-Bains SA (ENXTPA:MLHBB). As part of the transaction, Financiere Hoche Bains-Les-Bains SA (ENXTPA:MLHBB) acquired 1.54% stake in the company and Plant Advanced Technologies SA (ENXTPA:ALPAT) now holds 98.46% in the company.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
10.2 EUR | 0.00% | +4.08% | +20.71% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.71% | 11.86M | |
+3.13% | 43.43B | |
+48.54% | 41.69B | |
+8.49% | 41.31B | |
-10.82% | 27.14B | |
+8.26% | 25.28B | |
-23.69% | 18.47B | |
+1.58% | 12.33B | |
+32.83% | 12.59B | |
+6.63% | 11.03B |
- Stock Market
- Equities
- ALPAT Stock
- News Plant Advanced Technologies
- Temisis Therapeutics announced that it has received €1.6 million in funding from Financiere Hoche Bains-Les-Bains SA, Plant Advanced Technologies SA